Product Program year 2025 Source: CMS Open Payments

Penumbra Coil 400

Device Neurointervention

PDI 00814548018485

Open in the dashboard

General payments

$174,993

1,728 payments

Research payments

$0

0 payments

Through program year 2025, $174,993 in general payments and $0 in research payments were reported against Penumbra Coil 400 (Neurointervention).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $32,925 381
2024 General $24,457 416
2023 General $90,433 396
2022 General $19,898 425
2021 General $7,280 110

Breakdown

Who paid General payments · program years 2021–2025
  1. Penumbra, Inc. $174,993 1,728 payments
Top recipients General payments · program year 2025
  1. Aditya Iyer Neurological Surgery · Mission Hills, CA $2,261 7% · 11 payments
  2. Gabriel Vidal Vascular Neurology · New Orleans, LA $1,956 6% · 7 payments
  3. Justin Mascitelli Neurological Surgery · San Antonio, TX $1,167 4% · 4 payments
  4. Mario Zanaty Neurological Surgery · Iowa City, IA $1,166 4% · 4 payments
  5. Don Bell Neuroradiology · Las Vegas, NV $949 3% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurological Surgery $13,074 41% · 77 practitioners
  2. Neuroradiology Radiology $4,274 13% · 23 practitioners
  3. Diagnostic Radiology Radiology $3,239 10% · 28 practitioners
  4. Vascular Neurology Psychiatry & Neurology $2,613 8% · 10 practitioners
  5. Vascular & Interventional Radiology Radiology $2,338 7% · 19 practitioners

The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $6,696 20% · 34 recipients
  2. Florida $4,316 13% · 32 recipients
  3. Louisiana $2,875 9% · 7 recipients
  4. Nevada $2,666 8% · 14 recipients
  5. Oklahoma $2,063 6% · 5 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,728 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record